Effect of a low glycemic index diet versus a high-cereal fibre diet on markers of subclinical cardiac injury in healthy individuals with type 2 diabetes mellitus: An exploratory analysis of a randomized dietary trial.
Study Goal
The researchers aimed to determine whether a Low-Glycemic-Index (LGI) diet could reduce markers of subclinical cardiac injury (hs-cTnI) and fibrosis (galectin-3) in individuals with type 2 diabetes mellitus (T2DM) compared to a high-cereal fibre diet.
Results Summary
The study found no significant differences in changes to hs-cTnI or galectin-3 levels between the LGI and high-cereal fibre diets over 6 months. However, the LGI diet was noted as a viable option for diabetes and cardiovascular risk management due to the absence of adverse effects.
Population
Otherwise healthy individuals with type 2 diabetes mellitus (T2DM).
Effective Dosage
Not specified
Duration
6 months
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
low glycemic index (LGI) diet | no change | high-sensitivity cardiac troponin I (hs-cTnI) | otherwise healthy individuals with type 2 diabetes mellitus (T2DM) | -0.16ng/L vs. -0.22ng/L | no significant differences were observed for change | #1 |
low glycemic index (LGI) diet | no change | galectin-3 levels | otherwise healthy individuals with type 2 diabetes mellitus (T2DM) | 0.64μg/L vs. 0.14μg/L | no significant differences were observed for change | #2 |
low glycemic index (LGI) diet | no change | hs-cTnI and galectin-3 levels | otherwise healthy individuals with T2DM | - | effect was similar | #3 |
low glycemic index (LGI) diet | neutral | diabetes and cardiovascular disease risk management | - | - | remain an option for | #4 |
BACKGROUND: Markers of subclinical cardiac injury are elevated in individuals with type 2 diabetes mellitus (T2DM) compared to healthy individuals. Low glycemic index (LGI) diets may improve both diabetes and cardiovascular risk but their effects on cardiac injury and fibrosis have not been previously studied. To test the effect of a LGI diet on markers of subclinical cardiac injury and fibrosis, we assessed the effect of a LGI compared with a high-cereal fibre diet on high-sensitivity cardiac troponin I (hs-cTnI) and galectin-3 in otherwise healthy individuals with T2DM in an exploratory analysis of a completed randomized trial. METHODS: A total of 201 participants completed the trial and had measurements of hs-cTnI and galectin-3 at baseline and at trial completion. Participants were randomized to follow a LGI or a high-cereal fibre diet over a 6-month period. Treatment differences were tested using Analysis of Covariance (ANCOVA) with sex, baseline values, and diet x sex interaction included as covariates. RESULTS: In a completer's analysis, no significant differences were observed for change in hs-cTnI (-0.16ng/L vs. -0.22ng/L, p=0.713) and galectin-3 levels (0.64μg/L vs. 0.14μg/L, p=0.166) when a LGI diet was compared to a high-cereal fibre diet. CONCLUSIONS: The effect of a LGI diet was similar to a high-cereal fibre diet on hs-cTnI and galectin-3 levels in otherwise healthy individuals with T2DM over a 6-month period. Nevertheless, in the absence of any adverse effects, LGI diets remain an option for diabetes and cardiovascular disease risk management. ClinicalTrials.gov identifier: NCT00438698.